538 related articles for article (PubMed ID: 10493512)
1. Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells.
Shahan TA; Ziaie Z; Pasco S; Fawzi A; Bellon G; Monboisse JC; Kefalides NA
Cancer Res; 1999 Sep; 59(18):4584-90. PubMed ID: 10493512
[TBL] [Abstract][Full Text] [Related]
2. The alpha 3(IV)185-206 peptide from noncollagenous domain 1 of type IV collagen interacts with a novel binding site on the beta 3 subunit of integrin alpha Vbeta 3 and stimulates focal adhesion kinase and phosphatidylinositol 3-kinase phosphorylation.
Pasco S; Monboisse JC; Kieffer N
J Biol Chem; 2000 Oct; 275(42):32999-3007. PubMed ID: 10934203
[TBL] [Abstract][Full Text] [Related]
3. Regulation of tumor cell chemotaxis by type IV collagen is mediated by a Ca(2+)-dependent mechanism requiring CD47 and the integrin alpha(V)beta(3).
Shahan TA; Fawzi A; Bellon G; Monboisse JC; Kefalides NA
J Biol Chem; 2000 Feb; 275(7):4796-802. PubMed ID: 10671513
[TBL] [Abstract][Full Text] [Related]
4. Oncothanin, a peptide from the alpha3 chain of type IV collagen, modifies endothelial cell function and inhibits angiogenesis.
Shahan T; Grant D; Tootell M; Ziaie Z; Ohno N; Mousa S; Mohamad S; Delisser H; Kefalides N
Connect Tissue Res; 2004; 45(3):151-63. PubMed ID: 15512769
[TBL] [Abstract][Full Text] [Related]
5. An all-D amino acid peptide model of alpha1(IV)531-543 from type IV collagen binds the alpha3beta1 integrin and mediates tumor cell adhesion, spreading, and motility.
Li C; McCarthy JB; Furcht LT; Fields GB
Biochemistry; 1997 Dec; 36(49):15404-10. PubMed ID: 9398270
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumor cell proliferation by type IV collagen requires increased levels of cAMP.
Shahan TA; Ohno N; Pasco S; Borel JP; Monboisse JC; Kefalides NA
Connect Tissue Res; 1999; 40(3):221-32. PubMed ID: 10772543
[TBL] [Abstract][Full Text] [Related]
7. A specific sequence of the noncollagenous domain of the alpha3(IV) chain of type IV collagen inhibits expression and activation of matrix metalloproteinases by tumor cells.
Pasco S; Han J; Gillery P; Bellon G; Maquart FX; Borel JP; Kefalides NA; Monboisse JC
Cancer Res; 2000 Jan; 60(2):467-73. PubMed ID: 10667602
[TBL] [Abstract][Full Text] [Related]
8. A peptide of the alpha3 chain of type IV collagen protects basement membrane against damage by PMN.
Ziaie Z; Fawzi A; Bellon G; Monboisse JC; Kefalides NA
Biochem Biophys Res Commun; 1999 Aug; 261(2):247-50. PubMed ID: 10425173
[TBL] [Abstract][Full Text] [Related]
9. Effect of ligand conformation on melanoma cell alpha3beta1 integrin-mediated signal transduction events: implications for a collagen structural modulation mechanism of tumor cell invasion.
Lauer JL; Gendron CM; Fields GB
Biochemistry; 1998 Apr; 37(15):5279-87. PubMed ID: 9548759
[TBL] [Abstract][Full Text] [Related]
10. Analysis of integrin receptors for laminin and type IV collagen on metastatic B16 melanoma cells.
Ramos DM; Berston ED; Kramer RH
Cancer Res; 1990 Feb; 50(3):728-34. PubMed ID: 2153445
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by alpha(v)beta1 integrin and can be modulated by changes in beta1 integrin function.
Davison E; Kirby I; Whitehouse J; Hart I; Marshall JF; Santis G
J Gene Med; 2001; 3(6):550-9. PubMed ID: 11778901
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions.
Natali PG; Hamby CV; Felding-Habermann B; Liang B; Nicotra MR; Di Filippo F; Giannarelli D; Temponi M; Ferrone S
Cancer Res; 1997 Apr; 57(8):1554-60. PubMed ID: 9108459
[TBL] [Abstract][Full Text] [Related]
13. Involvement of integrins with adhesion-promoting, heparin-binding peptides of type IV collagen in cultured human corneal epithelial cells.
Maldonado BA; Furcht LT
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):364-72. PubMed ID: 7843907
[TBL] [Abstract][Full Text] [Related]
14. Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components.
Xue W; Mizukami I; Todd RF; Petty HR
Cancer Res; 1997 May; 57(9):1682-9. PubMed ID: 9135008
[TBL] [Abstract][Full Text] [Related]
15. Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival.
Petitclerc E; Strömblad S; von Schalscha TL; Mitjans F; Piulats J; Montgomery AM; Cheresh DA; Brooks PC
Cancer Res; 1999 Jun; 59(11):2724-30. PubMed ID: 10363998
[TBL] [Abstract][Full Text] [Related]
16. A peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy.
Carron CP; Meyer DM; Pegg JA; Engleman VW; Nickols MA; Settle SL; Westlin WF; Ruminski PG; Nickols GA
Cancer Res; 1998 May; 58(9):1930-5. PubMed ID: 9581835
[TBL] [Abstract][Full Text] [Related]
17. Synthetic peptides inhibit adhesion of human tumor cells to extracellular matrix proteins.
DeRoock IB; Pennington ME; Sroka TC; Lam KS; Bowden GT; Bair EL; Cress AE
Cancer Res; 2001 Apr; 61(8):3308-13. PubMed ID: 11309285
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of melanoma cell binding to type IV collagen by analogs of cell adhesion regulator.
Lauer JL; Furcht LT; Fields GB
J Med Chem; 1997 Sep; 40(19):3077-84. PubMed ID: 9301671
[TBL] [Abstract][Full Text] [Related]
19. Thrombospondin modulates alpha v beta 3 function through integrin-associated protein.
Gao AG; Lindberg FP; Dimitry JM; Brown EJ; Frazier WA
J Cell Biol; 1996 Oct; 135(2):533-44. PubMed ID: 8896608
[TBL] [Abstract][Full Text] [Related]
20. A monoclonal antibody inhibits adhesion to fibronectin and vitronectin of a colon carcinoma cell line and recognizes the integrins alpha v beta 3, alpha v beta 5, and alpha v beta 6.
Lehmann M; Rabenandrasana C; Tamura R; Lissitzky JC; Quaranta V; Pichon J; Marvaldi J
Cancer Res; 1994 Apr; 54(8):2102-7. PubMed ID: 7513610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
